AKT1 and breast cancer: Similarly, HSP90 knockdown via RNAi in breast cancer cell and xenograft models induced cell cycle arrest at G1/S phase and downregulated Akt and NF-κB signaling17, which suggests the potential anti-cancer role of HSP90 inhibition.